&nbsp;

HomeSafety_FR.pdf

Feb 2021

Manipulation sécuritaire des médicaments contre le cancer et des fluides corporels à la maison

Document

HomeSafety.pdf

Feb 2021

Document

obsp-18-2-21.xml

Feb 2021

Document

OBSP-18-2-21.html

Feb 2021

Regimen

CEDADECI

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

Exceptional Access Program

decitabine / cedazuridine - For the treatment of adult patients with myelodysplastic syndromes (MDS), according to clinical criteria

decitabine / cedazuridine

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

OLAP

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

Exceptional Access Program

olaparib - For the treatment of metastatic castration resistant prostate cancer (mCRPC), based on criteria

Drugs Used:

olaparib

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

AVEL(MNT)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Funding:

New Drug Funding Program

Avelumab - Maintenance Treatment for Unresectable Locally Advanced or Metastatic Urothelial Carcinoma

Drugs Used:

avelumab

Quick Link(s):

Regimen Monograph

Jan 2025

Regimen

CRBPNPAC

Cancer Type:

Gynecologic,

Cervix,

Endometrial,

Ovary

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes

Drugs Used:

nab-PACLitaxel,

CARBOplatin